tradmap

ROIV Earnings Roivant Sciences Ltd.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$1 $2 $5 $0 2022 2023 2024 2025 2026
EPS
Revenue (annual)
$0 $28M $55M 2021 2022 2023 2024 2025 2026
Revenue
Net income (annual)
-$1B $2B $4B $0 2021 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 $2 $5 $0 Q3 '22 Q2 '23 Q4 '23 Q3 '24 Q2 '25 Q4 '25
EPS
Revenue (quarterly)
$0 $8M $16M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$304M $2B $5B $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–21 of 21
Q1 20262026-06-30-0.262026-08-0610-Q
FY 20252026-03-31-0.542026-05-2010-K
Q3 20252025-12-31-0.882026-02-0610-Q
Q2 20252025-09-30-0.492025-11-1010-Q
Q1 20262025-06-30-0.332026-08-0610-Q
FY 20252025-03-31-0.242026-05-2010-K
Q3 20252024-12-310.052026-02-0610-Q
Q2 20252024-09-30-0.182025-11-1010-Q
Q1 20252024-06-300.122025-08-1110-Q
FY 20252024-03-315.232026-05-2010-K
Q3 20242023-12-315.462025-02-1010-Q
Q2 20242023-09-30-0.782024-11-1210-Q
Q1 20242023-06-30-0.382024-08-0910-Q
FY 20242023-03-31-1.422025-05-2910-K
Q3 20232022-12-31-1.392024-02-1310-Q
Q2 20232022-09-30-0.892023-11-1310-Q
Q1 20232022-06-30-0.482023-08-1410-Q
FY 20232022-03-31-1.262023-06-2810-K
Q3 20222021-12-31-0.872023-02-1310-Q
Q2 20222021-09-30-0.452022-11-1410-Q
Q1 20222021-06-30-0.132022-08-1510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.